Literature DB >> 36225989

Asymptomatic pleural thickening with effusion as the only manifestation of IgG4-related disease.

Shailesh Kolekar1, Katrine Fjaellegaard1,2,3, Jesper Koefod Petersen1,2,3, Karen Ege Olsen4, Paul Frost Clementsen1,5,6, Uffe Bodtger1,2,3.   

Abstract

Immunoglobulin G4 (IgG4)-related disease is a systemic fibroinflammatory disorder that can affect almost any tissue. Isolated IgG4 pleural disease is a rare manifestation and, when present, is usually described in patients presenting with dyspnoea. We present a case of asymptomatic isolated IgG4 pleural effusion and highlight that IgG4-related disease should be remembered as a differential diagnosis in patients with pleural effusion and pleural thickening, even if asymptomatic and without any other organ involvement.
© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Entities:  

Keywords:  Fibroinflammatory disorder; IgG4‐related disease; pleural fluid

Year:  2020        PMID: 36225989      PMCID: PMC9531709          DOI: 10.1002/rcr2.663

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


Introduction

Immunoglobulin G4 (IgG4)‐related disease is a systemic fibroinflammatory disorder that can lead to severe and irreversible organ damage [1] and has been reported to affect almost any tissue [2]. Isolated IgG4 pleural disease is a rare manifestation usually described in patients presenting with dyspnoea [3]. We present an asymptomatic case of isolated IgG4‐related pleural effusion.

Case Report

A 65‐year‐old man, non‐smoker with no exposure to asbestos, presented with few days of non‐specific malaise, dizziness, and no respiratory symptoms to his general practitioner. His symptoms resolved spontaneously, but as chest X‐ray showed a right‐sided pleural effusion, he was referred to our department for work‐up. Diagnostic ultrasound‐guided aspiration of 30 mL of clear serous pleural fluid revealed an exudative, culture‐ and cytology‐negative effusion. Contrast‐enhanced computed tomography (CT) of the thorax and abdomen confirmed a right‐sided pleural effusion and pleural thickening, normal lung parenchyma, and no other lesions (Fig. 1A). No abnormalities were found in the abdomen. A positron emission tomography‐CT (PET‐CT) showed increased metabolic activity in the thickened pleura and in morphologically normal mediastinal and hilar lymph nodes (Fig. 1B). Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) biopsies from normal size and appearance lymph nodes at stations 7, 4R, 11R, and 12R showed lymphatic tissue without granulomas or malignant cells. Bronchoscopy was normal. Serum antinuclear antibodies and rheumatoid factor were absent. Peptidyldipeptidase A and serum(s)‐interleukin 6 (IL6) was in the normal range, whereas s‐IgG4 was 7.15 (0.03–2.01 g/L). A right‐sided video‐assisted thoracic surgery (VATS) with pleural biopsies revealed fibrin coatings and pronounced underlying lymphoplasmacytic infiltration rich in IgG4‐positive plasma cells (absolute number of IgG4‐positive cells per high‐power field was 80 (>10) and IgG4/IgG was 27% (>40%)) without signs of monoclonality, malignancy, mesothelioma, or granulomas (Fig. 2). Biopsy culture for Mycobacterium tuberculosis was negative. A diagnosis of IgG4‐related disease was made according to guidelines. Treatment was not indicated but follow‐up with six‐monthly chest CT and blood tests is planned.
Figure 1

(A) Contrast‐enhanced computed tomography (CT) showing a minimal amount of pleural fluid and pleural thickening but no other lesions. (B) Positron emission tomography‐CT showing increased metabolic activity in the thickened pleura.

Figure 2

Pleural biopsy with massive lymphoplasmacytic inflammation. (A) Overview (100×). (B) Inflammation dominated by plasma cells (400×). (C) Immunohistochemical reaction for immunoglobulin G (IgG) (400×). (D) Immunohistochemical reaction for IgG4 (400×).

(A) Contrast‐enhanced computed tomography (CT) showing a minimal amount of pleural fluid and pleural thickening but no other lesions. (B) Positron emission tomography‐CT showing increased metabolic activity in the thickened pleura. Pleural biopsy with massive lymphoplasmacytic inflammation. (A) Overview (100×). (B) Inflammation dominated by plasma cells (400×). (C) Immunohistochemical reaction for immunoglobulin G (IgG) (400×). (D) Immunohistochemical reaction for IgG4 (400×).

Discussion

The epidemiology of IgG4‐related disease is poorly described due to the relative rarity but also of likely underrecognition. The diagnosis is difficult, as up to 5% of healthy subjects demonstrate an elevated level of s‐IgG4, and s‐IgG4 levels may be normal in patients with IgG4‐related disease [1]. In our patient, the s‐IgG4 level was elevated. The diagnosis of IgG4‐related disease cannot be based on biopsy alone as differential diagnoses must be excluded such as infection, tuberculosis, sarcoidosis, connective tissue disease, multicentric Castleman's disease (MCD), lymphoma, and solid malignancy [4]. In our case, neither blood tests, imaging nor tissue samples showed signs of any of these diseases. This was supported by the absence of symptoms of any kind. The incidence of asymptomatic IgG4‐related pleural effusion is unknown. Long‐term follow‐up is important, as IgG4‐related pleural effusion is an exclusion of diagnosis and there is a risk of complicating malignancy. We did not treat our patient with corticosteroids, as this is only recommended in case of vital organ involvement (e.g. aorta, heart, pancreas, or kidneys) to avoid irreversible organ damage [5]. In conclusion, asymptomatic pleural effusion and pleural thickening without any other organ involvement may be caused by IgG4‐related disease. This finding may represent a transient condition or the early manifestation of clinically significant IgG4‐related disease. We recommend long‐term surveillance for complicating malignancy.

Disclosure Statement

Appropriate written informed consent was obtained for publication of this case report and accompanying images.
  5 in total

1.  Proposed diagnostic criteria for IgG4-related respiratory disease.

Authors:  Shoko Matsui; Hiroshi Yamamoto; Seijiro Minamoto; Yuko Waseda; Michiaki Mishima; Keishi Kubo
Journal:  Respir Investig       Date:  2015-10-20

Review 2.  International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.

Authors:  A Khosroshahi; Z S Wallace; J L Crowe; T Akamizu; A Azumi; M N Carruthers; S T Chari; E Della-Torre; L Frulloni; H Goto; P A Hart; T Kamisawa; S Kawa; M Kawano; M H Kim; Y Kodama; K Kubota; M M Lerch; M Löhr; Y Masaki; S Matsui; T Mimori; S Nakamura; T Nakazawa; H Ohara; K Okazaki; J H Ryu; T Saeki; N Schleinitz; A Shimatsu; T Shimosegawa; H Takahashi; M Takahira; A Tanaka; M Topazian; H Umehara; G J Webster; T E Witzig; M Yamamoto; W Zhang; T Chiba; J H Stone
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

3.  IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.

Authors:  Zachary S Wallace; Vikram Deshpande; Hamid Mattoo; Vinay S Mahajan; Maria Kulikova; Shiv Pillai; John H Stone
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

4.  IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases.

Authors:  Yoh Zen; Dai Inoue; Azusa Kitao; Manabu Onodera; Hitoshi Abo; Shiro Miyayama; Toshifumi Gabata; Osamu Matsui; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

Review 5.  Pleural effusion related to IgG4.

Authors:  Yoriyuki Murata; Keisuke Aoe; Yusuke Mimura
Journal:  Curr Opin Pulm Med       Date:  2019-07       Impact factor: 3.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.